Working… Menu

A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03916042
Recruitment Status : Completed
First Posted : April 16, 2019
Last Update Posted : December 7, 2020
Information provided by (Responsible Party):
Aldeyra Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 22, 2019
Actual Study Completion Date : November 22, 2019
Certification/Extension First Submitted : December 2, 2020